Of particular significance, SMARCD1 (encoding BAF60a) demonstrated marked overexpression in HCC specimens, mechanistically linked to mTOR pathway activation via upstream potentiation of PI3K/AKT signalling—a mechanism directly implicated in HCC [61]. The gene discussed is MTOR; the disease is hepatocellular carcinoma.